Point Of Care (POC) Immunoassay Analyzer Expansion Market Report 2026

Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview

• Point Of Care (POC) Immunoassay Analyzer Expansion market size has reached to $4.9 billion in 2025 • Expected to grow to $7.45 billion in 2030 at a compound annual growth rate (CAGR) of 8.8% • Growth Driver: Growing Prevalence Of Infectious Diseases Fueling The Growth Of The Market Due To Increasing Disease Transmission And Diagnostic Demand • Market Trend: Advancements In Immunoassay Technologies Enhance Rapid Diagnostics And Real-Time Clinical Decision-Making In Decentralized Settings • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Point Of Care (POC) Immunoassay Analyzer Expansion Market?

Point-of-care immunoassay analyzer expansion is a healthcare technology that focuses on the development, production, and deployment of point-of-care immunoassay analyzers for rapid, near-patient diagnostic testing. These analyzers use immunoassay techniques to detect specific proteins, hormones, antigens, or antibodies in biological samples such as blood, urine, or saliva, providing fast and accurate results for clinical decision-making. The main product types of point of care immunoassay analyzer expansion include portable analyzers, benchtop analyzers, and microfluidic analyzers. Portable analyzers refer to compact diagnostic devices designed for rapid immunoassay testing at or near the patient site, enabling quick clinical decision-making. These solutions are based on technologies such as chemiluminescence, enzyme-linked immunosorbent assay, and lateral flow assay and they utilize sample types including blood, urine, and saliva. The applications involved are infectious diseases, hormonal testing, autoimmune disorders, cardiac markers, and oncology, while the end-use includes hospitals, diagnostic laboratories, home care settings, and academic research institutions.

What Is The Point Of Care (POC) Immunoassay Analyzer Expansion Market Growth Forecast?

The point of care (POC) immunoassay analyzer expansion market size is expected to see strong growth in the next few years.It will grow to $7.45 billion by 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to expansion of personalized medicine and biomarker-based testing, increasing shift toward decentralized healthcare delivery, rising adoption of ai-enabled diagnostic systems, growth in home-based healthcare monitoring, increasing regulatory approvals for rapid diagnostic devices.Major trends in the forecast period include expansion of decentralized point-of-care diagnostic ecosystems, increasing adoption of multiplex immunoassay platforms, integration of wireless connectivity in portable analyzers, growth of cartridge-based rapid testing systems, rising demand for at-home immunodiagnostic solutions.

Global Point Of Care (POC) Immunoassay Analyzer Expansion Market Segmentation

1) By Product Type: Portable Analyzers, Benchtop Analyzers, Microfluidic Analyzers 2) By Technology: Chemiluminescence, Enzyme-Linked Immunosorbent Assay, Lateral Flow Assay 3) By Sample Type: Blood, Urine, Saliva 4) By Application: Infectious Diseases, Hormonal Testing, Autoimmune Disorders, Cardiac Markers, Oncology 5) By End User: Hospitals, Diagnostic Laboratories, Home Care Settings, Academic Research Institutions Subsegments: 1) By Portable Analyzers: Handheld Immunoassay Analyzers, Battery Operated Diagnostic Analyzers, Wireless Connected Portable Analyzers, Single Test Portable Analyzers, Multi Test Portable Analyzers 2) By Benchtop Analyzers: Compact Laboratory Benchtop Analyzers, High Throughput Benchtop Analyzers, Fully Automated Benchtop Analyzers, Semi Automated Benchtop Analyzers, Multi Assay Benchtop Systems 3) By Microfluidic Analyzers: Lab On A Chip Analyzers, Cartridge Based Microfluidic Analyzers, Continuous Flow Microfluidic Systems, Droplet Based Microfluidic Analyzers, Integrated Microfluidic Diagnostic Systems

What Is The Driver Of The Point Of Care (POC) Immunoassay Analyzer Expansion Market?

The growing prevalence of infectious diseases is expected to propel the growth of the point of care immunoassay analyser expansion market going forward.Infectious diseases are disorders caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi that spread directly or indirectly between individuals.The growing prevalence of infectious diseases is driven by increasing global population density, which accelerates transmission risks and disease spread.Point of care (POC) immunoassay analyzers expansion support the prevalence of infectious diseases by enabling rapid, accurate, and decentralized detection of infectious biomarkers, which strengthens early diagnosis and disease control efforts.For instance, in March 2025, according to the UK Health Security Agency, a UK-based government health authority, tuberculosis cases in england increased by 13% in 2024, reaching 5,480 cases compared to 4,850 cases in 2023.Therefore, the growing prevalence of infectious diseases is driving the growth of growth of the point of care immunoassay analyzer expansion market.

Key Players In The Global Point Of Care (POC) Immunoassay Analyzer Expansion Market

Major companies operating in the point of care (poc) immunoassay analyzer expansion market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Becton, Dickinson and Company (BD), Beckman Coulter, Bruker Corporation, BioRad Laboratories, Qiagen N. V., Diasorin, Lepu Medical Technology, SD Biosensor, Eiken Chemical Co. Ltd., Molbio Diagnostics Pvt. Ltd., Maccura Biotechnology Co. Ltd., QuantuMDx Group Ltd., Ustar Biotechnologies Ltd., Mylab Discovery Solutions Pvt Ltd., Akonni Biosystems Inc., Zeesan Biotech Co. Ltd.

Global Point Of Care (POC) Immunoassay Analyzer Expansion Market Trends and Insights

Major companies operating in the point of care immunoassay analyser expansion market are focusing on developing innovative solutions, such as advancements in immunoassay technologies, to meet the rising demand for rapid diagnostics, decentralized healthcare, and real-time clinical decision-making in emergency and remote settings. These advanced immunoassay analyzers are compact diagnostic platforms that utilize antigen–antibody reactions to detect biomarkers with high sensitivity, offering features such as rapid turnaround times, portability, minimal sample preparation, and multiplex testing capabilities; unlike traditional centralized laboratory analyzers that require sophisticated infrastructure and longer processing times, POC systems enable near-patient testing with faster results and improved accessibility. For instance, in July 2023, Anbio Biotechnology, a China-based diagnostics company, launched the AF-100S Fluorescence Immunoassay Analyzer. This system is a compact, automated fluorescent immunoassay analyzer designed for rapid quantitative detection of biomarkers in clinical samples such as whole blood, serum, and plasma. It integrates fluorescence-based detection technology with automated calibration and built-in quality control to ensure high sensitivity and accuracy comparable to centralized laboratory systems. Additionally, the analyzer features a user-friendly interface and delivers test results within minutes, making it highly suitable for emergency departments, clinics, and decentralized healthcare settings.

What Are Latest Mergers And Acquisitions In The Point Of Care (POC) Immunoassay Analyzer Expansion Market?

In August 2024, Roche, a Switzerland-based healthcare company, acquired LumiraDx’s point-of-care technology assets for an undisclosed amount. Through this acquisition, Roche aims to strengthen its diagnostics portfolio by integrating LumiraDx’s innovative point-of-care testing platform, which includes immunoassay-based diagnostic capabilities, and expanding its presence in decentralized healthcare solutions. LumiraDx is a UK-based diagnostics company specializing in rapid, point-of-care testing technologies.

Regional Insights

North America was the largest region in the point-of-care immunoassay analyzer expansion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Point Of Care (POC) Immunoassay Analyzer Expansion Market?

The point-of-care immunoassay analyzer expansion market consists of revenues earned by entities by providing services such as analyzer installation, calibration, maintenance, cloud-based data connectivity, software integration, remote monitoring, and consumable supply services. The market value also includes the value of related goods sold by the service provider or included within the service offering. The point-of-care immunoassay analyzer expansion market also includes sales of POC immunoassay analyzers, peripheral devices, biosensors, handheld analyzers, automated test systems, sample preparation devices, and associated accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream healthcare providers, distributors, or retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

What is the Market Assessment and Strategic Outlook for the Point Of Care (POC) Immunoassay Analyzer Expansion Industry?

The point of care (poc) immunoassay analyzer expansion market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the point of care (poc) immunoassay analyzer expansion industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

What is the Market Assessment and Strategic Outlook for the Point Of Care (POC) Immunoassay Analyzer Expansion Market Report 2026?

The point of care (POC) immunoassay analyzer expansion market research report is one of a series of new reports from The Business Research Company that provides point of care (POC) immunoassay analyzer expansion market statistics, including point of care (POC) immunoassay analyzer expansion industry global market size, regional shares, competitors with a point of care (POC) immunoassay analyzer expansion market share, detailed point of care (POC) immunoassay analyzer expansion market segments, market trends and opportunities, and any further data you may need to thrive in the point of care (POC) immunoassay analyzer expansion industry. This point of care (POC) immunoassay analyzer expansion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.